HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frontal cortex chitinase and pentraxin neuroinflammatory alterations during the progression of Alzheimer's disease.

AbstractBACKGROUND:
Chitinase 3-like 1 (CHI3L1), chitinase 3-like 2 (CHI3L2), and neuronal pentraxin II (NPTX2) are inflammatory biomarkers of Alzheimer's disease (AD). Although studies have demonstrated that cerebrospinal fluid levels of these proteins are changed in AD, no studies have undertaken a detailed examination of alterations in protein levels, cellular expression, and interaction with amyloid in the brain during the progression of AD.
METHODS:
The study evaluated levels of both CHI3L1 and CHI3L2, NPTX2, ionized calcium-binding adapter molecule 1 (Iba1), complement component 1q (C1q), glial fibrillary acidic protein (GFAP), and CD44, in the frontal cortex of people who died with an antemortem clinical diagnosis of no cognitive impairment (NCI), mild cognitive impairment (MCI), mild/moderate AD (mAD), and severe AD (sAD) using immunoblot and immunohistochemical techniques.
RESULTS:
CHI3L1-immunoreactive (-ir) astrocyte numbers were increased in the frontal cortex and white matter in sAD compared to NCI. On the other hand, increases in GFAP and Iba1-ir cell numbers were observed in MCI compared to NCI but only in white matter. Western blot analyses revealed significantly lower frontal cortex CHI3L2 levels, whereas CD44 levels were increased in sAD. No significant differences for CHI3L1, GFAP, C1q, and NPTX2 protein levels were detected between clinical groups. Strong significant correlations were found between frontal cortex CHI3L1 and Iba1-ir cell numbers in white matter and CHI3L1 and C1q protein levels in the early stages of the disease. C1q and Iba1, CD44 with CHI3L2, and GFAP protein levels were associated during disease progression. CHI3L1 and Iba1 cell numbers in white matter showed a significant associations with episodic memory and perceptual speed.
CONCLUSIONS:
White matter CHI3L1 inflammatory response is associated with cognitive impairment early in the onset of AD.
AuthorsMarta Moreno-Rodriguez, Sylvia E Perez, Muhammad Nadeem, Michael Malek-Ahmadi, Elliott J Mufson
JournalJournal of neuroinflammation (J Neuroinflammation) Vol. 17 Issue 1 Pg. 58 (Feb 17 2020) ISSN: 1742-2094 [Electronic] England
PMID32066474 (Publication Type: Journal Article)
Chemical References
  • CHI3L1 protein, human
  • Chitinase-3-Like Protein 1
  • Inflammation Mediators
  • Nerve Tissue Proteins
  • neuronal pentraxin
  • C-Reactive Protein
  • CHI3L2 protein, human
  • Chitinases
Topics
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease (metabolism, pathology)
  • C-Reactive Protein (analysis, metabolism)
  • Chitinase-3-Like Protein 1 (analysis, metabolism)
  • Chitinases (analysis, metabolism)
  • Disease Progression
  • Female
  • Frontal Lobe (metabolism, pathology)
  • Humans
  • Inflammation Mediators (analysis, metabolism)
  • Male
  • Nerve Tissue Proteins (analysis, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: